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Abstract
As part of an international effort to develop vaccines for Theileria lestoquardi, we undertook
a limited screen to test T. lestoquardi orthologuesof antigens recognised by CD8+ T lym-
phocyte responses against T. annulata and T. parva in cattle. Five MHC defined sheep were
immunized by live T. lestoquardi infection and their CD8+ T lymphocyte responses deter-
mined. ThirteenT. lestoquardi orthologuesof T. parvaand T. annulata genes, previously
shown to be targets of CD8+ T lymphocyte responses of immune cattle, were expressed in
autologous fibroblasts and screened for T cell recognition using an IFNγ assay. Genes
encoding T. lestoquardi antigens Tl8 (putative cysteine proteinase, 349 aa) or Tl9 (hypothet-
ical secreted protein, 293 aa) were recognise by T cells from one animal that displayed a
uniqueMHC class I genotype. Antigenic 9-mer peptide epitopes of Tl8 and Tl9 were identi-
fied through peptide scans using CD8+ T cells from the responding animal. These experi-
ments identify the first T. lestoquardi antigens recognised by CD8+ T cell responses linked
to specific MHC class I alleles.
Introduction
Theileria species are tick-transmitted hemoprotozoan parasites infectingwild and domestic
ungulates in many areas of the world. The most economically important species are T. parva
and T. annulata, which are pathogenic to cattle, and T. lestoquardi (formerly T. hirci), which is
pathogenic to sheep. Sheep are valuable commodities in North Africa, Asia, and the Middle
East, and there is a need for better prevention and/or treatment measures in order to reduce
the economic burden of disease caused by T. lestoquardi.
Infection with T. lestoquardi causes an acute disease known as malignant ovine theileriosis.
Clinical signs include loss of condition, coughing, lethargy, enlargement of lymph nodes, and
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fever [1]. Mortality levels of up to 73% have been reported for malignant ovine theileriosis [2]
and the disease can lead to reduced productivity and spontaneous abortions in survivors [3]. T.
lestoquardi is transmitted by Hyalomma anatolicum ticks [4] and possibly otherHyalomma
spp. [5, 6] and, as with most vector-borne diseases, control of transmission is challenging [7].
In addition, current disease control methods are limited to treatment with a theilericidal com-
pound, buparvaquone [8, 9], and in some countries, vaccination with attenuated parasitized
cell lines [10–12]. These methods are not easy to apply successfully. Preparation of attenuated
T. lestoquardi- infected cell line vaccines suitable for vaccination requires prolonged in vitro
passage and thorough testing in vivo, and distribution of the vaccine is dependent on a cold
chain. There are also issues with quality control, reproducibility and potential reversion to viru-
lence [13, 14]. Furthermore, the mechanisms of attenuation are only partially understood [14–
16]. A subunit vaccine would circumvent the logistical constraints of attenuated cell line vac-
cines. However, development of a subunit vaccine requires a greater understanding of protec-
tive immune responses against T. lestoquardi and the antigens that they recognise.
Studies of immune responses to, and antigen identification in, T. lestoquardi are lagging
behind those for T. parva and T. annulata for which antigens were identified through screening
of random T. parva and selectedT. annulata and T. parva schizont cDNA clones with potential
to transform host cells [17–19]. Although the disease produced by these parasites and the
immune responses they induce are very similar, evidence of genetic and antigenic similarities
are most evident for T. lestoquardi and T. annulata. These include cross-reactivity of T. lesto-
quardi antisera with T. annulata antigens [20], serological identification of T. lestoquardi pro-
teins with amino acid sequence similarity to T. annulata and T. parva [21, 22], infection of
similar cell types by T. lestoquardi and T. annulata in sheep and cattle respectively [23], and
the higher similarity betweenT. lestoquardi and T. annulata 18S rRNA sequences [24]. There
have been no reports on cellular responses to antigens conserved across T. lestoquardi, T. annu-
lata and T. parva; but these may occur given the identification of a conservedT cell antigen
betweenT. annulata and T. parva [19].
There is evidence that immunity to T. parva and T. annulata in cattle involves T cell medi-
ated responses; both CD4+ and CD8+ T cells recognise parasitized leukocytes [25, 26]. An
important role for CD8+ T cell responses in protection against T. parva has been demonstrated
by adoptive transfer of immune CD8+ T cells [27], and it has been proposed that help from
CD4+ T cells may also be required [28]. CD8+ T cell responses to T. parva and T. annulata
antigens are MHC class I restricted [29, 30], and in individual animals the responses are fre-
quently focused on a few immunodominant antigens, which differ depending on the MHC
genotype of the animal [19, 31].
Based on genetic and pathogenic similarities of T. lestoquardi to T. annulata and T. parva,
we propose that similar responses are likely to be involved in immunity against T. lestoquardi
and that recognition of immunodominant T cell antigens orthologous to those of T. annulata/
T. parvamay occur. This study, therefore, aimed to obtain evidence of induction of CD8+ T
cell responses by T. lestoquardi and to identify parasite antigens recognised by the specific
CD8+ T cell response based on screening orthologues of those recognised in T. annulata and T.
parva.
Methods
Ethics statement
Animal care and use were approved by the Royal Veterinary College Ethics Committee with
the Home Office Project licence number PPL 60/3736. Animal work was carried out in accor-
dance with the UK government Animals (Scientific Procedures) Act (ASPA) 1986.
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Animals
Five adult Swaledale/Leicester cross sheep (approximately 4 years old) were used in this study.
Animals were euthanized at the end of the study with lethal injection of barbituates.
Immunization
Sheep were immunized by subcutaneous administration of 1–3 × 106 cells of the T. lesto-
quardi-infected cell line, THS1 [32], as previously described [11]. Sheep were treated with
buparvaquone (2.5mg kg-1, Bimeda, Ireland) if fever persisted for two consecutive days. One
week after recovery from clinical reactions, sheep were re-challenged with the same number of
autologous parasitized cells without treatment to confirm and boost their immunity. Health of
the sheep was monitored by daily measurement of rectal temperature and palpation of the
draining lymph node.
MHC class I and II genotyping
MHC class I genotyping was carried out as previously described [33] with some modifications.
Total RNA was extracted with the Qiagen RNeasy Mini kit from cryopreserved lymphocytes of
T. lestoquardi-infected sheep. Contaminating DNA was removed with the Turbo DNA-free™
kit (Applied Biosystems) before cDNA synthesis, which was carried out using the AMV Long-
Amp1 Taq RT-PCR kit (New England Biolabs). Partial MHC class I sequences were amplified
from cDNA samples using class I generic primers 416 (5' CGGCTACGTGGACGACAYG 3')
and Cr (5' ATGGGTCACATGTGYCTTTG3'), which bind within exons 1 and 3 [33], generat-
ing a 500 bp product. The cycling conditions for PCR were 94°C for 4 min, 30 cycles 94°C for
30 s, 55°C for 30 s, and 72°C for 30 s, with Promega Go Taq DNA polymerase. Amplicons were
gel purified (QIAquick Gel Extraction kit, Qiagen) and Sanger sequenced (Eurofins UK) using
the same primer set, resulting in multiple sequences of different alleles. Individual class I
sequenceswere determined by cloning the purified amplicons into pGEM1-T Easy vector (Pro-
mega). Thirty transformants per sample were selected for bidirectional Sanger sequencingwith
vector-specificT7 and SP6 primers. Class I sequences were aligned using the SeqMan Pro pro-
grammewithin the DNASTAR Lasergene 11 package, and a consensus sequences of each allele
was generated from a minimum of 3 independent clones. Each consensus allelic sequencewas
BLASTN searched against an in house database of known ovine class I sequences. Novel alleles
were added to this database, and assigned a unique name that reflects the order in which they
were identified.MHC class II genotyping was carried out as previously described [34]. The novel
class IIDRB1 sequencewas validated by cloning the complete second exon sequence. The
sequencewas submitted to the ENA and IPD-MHC database for an official allelic nomenclature.
Generation of T. lestoquardi infected cell lines
T. lestoquardi-infected cell lines were obtained from peripheral blood or lymph nodes of
infected sheep. Blood or lymph node aspirates taken from the draining lymph node nearest the
site of challenge were collected daily in Alsever’s solution (Sigma Aldrich), from day 12 post-
infection but before treatment with buparvaquone [35]. PBMC and lymph nodemononuclear
cells were separated from the blood or lymph node aspirate using Ficoll-Paque (GE Life Sci-
ences) according to the manufacturer’s recommendations, and resuspended in culture medium
(RPMI 1640 Glutamax medium, Life Technologies, Gibco, Paisley, UK) supplemented with
10% FCS (GIBCO), penicillin-streptomycin (5000 units ml-1 and 5 mg ml-1, respectively,
Sigma-Aldrich,Dorset, UK) and 50 μM of 2-mercaptoethanol (Sigma Aldrich). PBMC and/or
lymph node cells were counted and dispensed at 2.5 × 106–1 × 107 cells per well in 2 ml culture
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medium in 24 well plates and cultured until parasitized cell lines were established [35]. The cul-
tures were incubated at 37°C in 5% CO2.
Cloning of candidate T. lestoquardi genes
Total RNA was extracted from T. lestoquardi-infected PBMC of the study sheep, using either
the RNeasy Mini Kit (Qiagen) or Trizol (Invitrogen), and cDNA was prepared using either
AMV First strand cDNA synthesis kit (New England Biolabs) or QuantiTect Reverse Tran-
scription kit (Qiagen). PCR was carried out either with Phusion Mastermix (Thermo Scientific)
or PfuDNA polymerase (Promega), and T. lestoquardi gene-specific primers were used for
amplification of full-length cDNA (S1 Table). An exception was antigen Tl12, which was
amplified from genomic DNA of T. lestoquardi infected PBMC. Genomic DNA was extracted
using the DNeasy Blood and Tissue kit (Qiagen). Amplicons were cloned into a modified
pMax expression vector (Lonza), containing a C-terminal V5-tag, by restriction-ligation.
Exceptions were Tl2, Tl13245 (orthologue of T. annulata TA13245), and Tl16020 (orthologue
of T. annulata TA16020), which were first cloned into pJET1.2 (Thermo Scientific) for gene
amplification and then cloned into pMax either by restriction-ligation, or by sequence and liga-
tion-independent cloning (SLIC) [36] (S1 Table). Briefly, SLIC involved linearization of pMax
either by digestion with EcoRV and ScaI (Fermentas), or by inverse PCR with primers pMax_-
EcoRV and pMax_XhoI (S1 Table). Insert amplicons, generated from primers containing gene
and vector-specific sequences, were purified and mixed with linearized vector, 0.6–1.5 U T4
DNA polymerase (New England Biolabs), 1 × BSA, and 1 × NEB Buffer 2 for 2.5 min. Recom-
binant plasmids of Tl1, 2, 3, 5, 6, 7, 8, 9, 10, 12, 16, 13245, or 16020 were transformed in either
DH5α or DH10B cells (NEB, UK) and selected on LB plates supplemented with kanamycin
(50 μg ml-1). Recombinant plasmids were Sanger sequenced to validate insert identity.
Culture of sheep skin fibroblast
Skin biopsies of approximately 1 cm2 were taken from immunized sheep to establish fibroblast
cell lines with matching MHC to effector cells from the same sheep. Skin biopsies were washed
in culture medium (RPMI with 10% FCS, and penicillin (5000 units ml-1)-streptomycin (5 mg
ml-1)), cut into small pieces, adhered onto culture dishes mechanically, and air-dried for 1 h.
Skin was then covered with culture media and incubated at 37°C in 5% CO2 for 1–3 weeks, or
until fibroblast grew onto plastic wells. Culture media was changed weekly. Fibroblast cell lines
were passaged every 3–4 days or as they reached confluency.
Transfection of ovine fibroblasts with T. lestoquardi antigenic genes
Plasmids for transfections were prepared from a single batch of 25 ml bacterial cultures using
the Qiagen PlasmidMidi kit. Autologous fibroblast cells were seeded in 96 well plates at
1 × 104 per well in 100 μl of culture medium and incubated overnight at 37°C in 5% CO2.
Transfection was carried out either with Lipofectamine LTX & Plus Reagent (Invitrogen) or
Fugene (Promega) at reagent (μl): DNA (μg) ratios of 5:1 and 3:1, respectively. Lipofectamine
transfected fibroblasts at 24 h and 48 h were examined for V5 tag expression by immunofluo-
rescence as describedpreviously [37]. Briefly, fibroblasts were seeded at 5 × 104 per well in 1 ml
culture medium on glass coverslips in 24 well plates and incubated overnight at 37°C in 5%
CO2. Cells were transfected either for 24 h or 48 h, fixed with 4% paraformaldehyde (Sigma
Aldrich) and permeabilizedwith 0.2% Triton-X (Sigma Aldrich) for 10 min each. Cells were
then blockedwith 10% FCS for 30 min before incubationwith anti-V5 mouse antibody (diluted
1:500, Invitrogen) for 1 h, followed by incubationwith an anti-mouse goat antibody AlexaFluor
488 (diluted 1:1500, Invitrogen). Cells were counter-stained with 1 μMDAPI (Life
Theileria lestoquardiAntigens
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Technologies) for 10 min, coverslips were blotted dry and mounted onto glass slides for
microscopy with DAKO fluorescencemounting medium (Agilent Technologies). Fluorescence
microscopy was carried out using an Olympus BX60 at 1000 × magnification, using appropri-
ate filter cubes and the CoolLEDpE excitation system (Nikon, UK). Images were captured
using the Image-Pro Plus 5.0 (MediaCybernetics).
Stimulation and enrichmentof CD8+ T cells
CD8+ T cells were prepared as previously describedwith slight modifications [38]. PBMC
(effectors) were collected from immunized sheep at 28 days post immunization. Gamma irradi-
ated (100 Gy) autologous T. lestoquardi infected cell lines generated as described above were
used as stimulators. Effectors and stimulators were co-cultured at an effector to stimulator
ratio of 20:1 in 2 ml of culture medium in 24 well plates, and incubated at 37°C for one week in
5% CO2. Cells were then harvested and dead cells removed using Ficoll-Paque (GE Life Sci-
ences). Viable effector cells were re-stimulated again at an effector to stimulator ratio of 10:1.
After an additional week, cells were harvested, separated on Ficoll-Paque, and enriched for
CD8 by complement fixation to remove CD4, γδ T cells and NK T cells. To do so, a cocktail of
the followingmouse-anti sheep or bovine antibodies, each at 8 μg ml-1, was used: anti-CD4+ T
cells (MCA2213GA; AbD Serotec), anti-γδ T cells (MCA838G; AbD Serotec), anti-NK T cells
(MCA5933GA; AbD Serotec). The cocktail was added to 5 × 107 ml-1 effector cell suspension
in equal volumes, for a final concentration of 4 μg ml-1 per antibody. The mixture was incu-
bated on ice for 30 min for opsonisation to take place. One part of rabbit serumwas added to
two parts of the cells/antibodymixture and incubated at 37°C for 45 min. Thereafter, cells were
washed in 10 ml culture medium, rested at 37°C for 2–3 h, spun on Ficoll-Paque to remove
debris and harvested cells plated at 5 × 103 per well in a 96 well plate. Cells were re-stimulated
with 1 × 103 irradiated T. lestoquardi cells in the presence of 100 U ml-1 of recombinant human
(rhu) IL-2 (Proleukin1, Novartis). The cultures were incubated at 37°C in 5% CO2 and used
as effectors in an IFNγ production assay 14–21 days later.
Phenotyping of enrichedT cells
The phenotype of effector T cell populations was determined by FACS analysis using antibod-
ies described above, as well as mouse- antisheep or antibovineMHC class I (MCA2444GA;
AbD Serotec), B-cell (MCA2443GA; AbD Serotec) and CD8 (MCA2216GA; AbD Serotec).
Cells (2 × 105–1 × 106) were mixed with an equal volume of primary antibody (final concentra-
tion 1 μg ml-1), incubated at 4°C for 30 min, washed three times using PBS, and resuspended in
50 μl FACS medium (2% horse serum in PBS). FITC-labelled goat anti-mouse IgG (AbD Sero-
tec) was used as secondary antibody. Cells were incubated at 4°C for 30 min, washed as before
and resuspended in FACSFlow (BectonDickinson Biosciences) for data acquisition and analy-
sis using either a FACSCalibur (BectonDickinson Biosciences) or a FACSAria (BectonDickin-
son Biosciences).
Cytotoxicity assay
T. lestoquardi infected cell lines (targets) were labelled with Indium oxine (111In) (GE Health-
care UK) by incubating 50 μl (1 × 106) cells with 0.185 Mbq of 111In for 15 min at 37°C.
Labelled target cells were washed six times in washing medium (RPMI 1640 Glutamax medium
with 2% FCS) then resuspended in culture medium. Effector cells, either in stimulated whole
PBMC or stimulated and enriched CD8+ T cells prepared with T. lestoquardi-infected cell lines
as described above, were mixed with labelled target cells in duplicates in two-fold dilutions
starting at 80:1 in a final volume of 150 μl. Positive controls consisted of labelled target cells
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lysed with 100 μl of 0.2% Tween20, negative controls were unlabelled target cells, and all con-
trols were performed in triplicate. Cells were incubated for 4 h at 37°C, resuspended in the
same volume of culture medium and centrifuged at 250 × g for 10 min. Seventy-five μl of
supernatant from each sample was measured for radioactivity in a gamma counter (WALLAC
1470, Perkin Elmer). Percentage cytotoxicity was calculated as release of 111In according to 100
× (test release–medium release) / (Tween20 release–medium release).
IFNγELISA
Fibroblasts transfected with plasmid DNA or treated with peptides overnight were washed
three times before addition of 2.5 × 105 effector cells per well in 200 μl culture medium, and
incubated for 72 h at 37°C in 5% CO2. Cell supernatants were harvested and analysed by IFNγ
ELISA, according manufacturer’s instruction (MABTECHTM); ELISA reactions were recorded
on a SpectraMaxM2 (Molecular Devices) plate reader. All assays included the following con-
trols: culture medium only, fibroblast only, effectors only, effectors and stimulators, fibroblast
and stimulators, fibroblast transfected with plasmid expressing GFP, and for peptide assays—
fibroblasts transfected with plasmid expressing Tl8 or Tl9.
Peptide library designs
Peptides derived from the amino acid sequences of Tl8 and Tl9 were synthesized as 17-mers
with 12 aa overlapping (JPT Peptide Technologies, Germany). Sixty-eight Tl8 peptides and 57
Tl9 peptides were tested. Peptides (approx. 67 nmol) were resuspended in RPMI in a 96 well
format. Up to 8 peptides in the same row were pooled, and up to 10 peptides in the same col-
umn were pooled so that each peptide was present in both row and column pools and used for
IFNγ assay. Peptide pools (1 μg ml-1 per peptide) were incubated with fibroblasts in 200 μl cul-
ture medium for IFNγ ELISA, and putative positive peptides were confirmed by peptide titra-
tion (0.01–10 μg ml-1) in the IFNγ assay. T cell epitope sequences were further examined by
synthesizing 9–12-mer peptides of each epitope truncated sequentially either at the N or C ter-
minal (JPT Peptide Technologies, Germany). Peptides were dissolved in up to 20% DMSO in
PBS to 10 mg ml-1, then diluted in RPMI for IFNγ assays at 1–10 μg ml-1 as above.
Nucleotide sequences
OvineMHC class I and II allele sequences were deposited in the European Nucleotide Archive
with accession numbers LN868342 –LN868359 and HF954377 (Table 1). T. lestoquardi gene
sequences were deposited in Genbank with accession numbers KT989585—KT989597
(Table 2).
Results
Genotyping of MHC class I and II alleles
Class I and class IIDRB1 allele expression for each of the five immunized animals were deter-
mined by sequencing of cloned PCR products. All identified class I sequences represented
novel alleles with the exception of allele U, which was identified in an earlier unpublished
study (Table 1). Comparison of the predicted amino acid sequences of the novel alleles to the
reference sequenceN00301 shows regions of polymorphism, particularly where residues were
predicted to interact with peptides (S1 Fig). Class II sequence based genotyping identified a
newDRB1 allele (DRB11802) in animal 1263 and previously identifiedDRB1 alleles in the
other animals; none of the alleles were shared between the five animals (Table 1).
Theileria lestoquardiAntigens
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Cytotoxic activity of CD8+ T cells from immunized sheep
CD8+ T cell responses of sheep immunized with live parasites were examined by in vitro stimu-
lation of PBMC with irradiated autologous parasitized cells and testing the responding cells in
a cytotoxicity assay using the same infected cells as targets. CD8+ T cell lines were established
from all five immunized sheep following two or three in vitro antigen stimulations and then
enrichment for CD8+ T cells by complement-mediated lysis of CD4 T cells; CD8+ T cells were
the predominant cell type (66.95 ± 0.014%) in these lines (S2 Fig). CD8+ T cells from each
Table 1. MHC class I and II alleles identified for individualsheep.
Animal Class I sequences (Accessionnumber)a Class II DRB (Accession
number)
Reference
1263 Ovar-I*2K (LN868358),Ovar-I*U (LN868342),Ovar-I*2L (LN868359) Ovar-DRB1*1802 homozygous
(HF954377)
This study
1343 Ovar-I*V (LN868343),Ovar-I*W (LN868344),Ovar-I*X (LN868345) Ovar-DRB1*0801,Ovar-
DRB1*1201
[39]
1360 Ovar-I*U (LN868342),Ovar-I*V (LN868343),Ovar-I*Y (LN868346),Ovar-I*Z (LN868347) Ovar-DRB1*0501 homozygous [39]
4223 Ovar-I*2A (LN868348),Ovar-I*2B (LN868349),Ovar-I*2C (LN868350),Ovar-I*2D (LN868351),
Ovar-I*2E (LN868352),Ovar-I*2F (LN868353)
Ovar-DRB1*1201,Ovar-
DRB1*0201
[39]
4247 Ovar-I*2G (LN868354),Ovar-I*2H (LN868355),Ovar-I*2I (LN868356),Ovar-I*2J (LN868357) Ovar-DRB1*1102,Ovar-
DRB1*0702
[39]
a Local name assigned for partialmRNA sequence.
doi:10.1371/journal.pone.0162571.t001
Table 2. Candidategenes for antigen screening.
Gene product,
size
TA orthologues,% ID TP orthologues, % ID Putative functionof
orthologues
GenBank
accessionno.
Reference
Tl1, 454 aa TA17450, 305/532
(57.3%)
TP03_0849 (Tp1), 209/557 (37.5%) Hypothetical protein KT989585 [17, 19]
Tl2, 177 aa TA19865 (Ta2), 149/178
(83.7%)
TP01_0056 (Tp2), 109/177 (61.6%) Surface protein d precursor KT989586 [17, 19]
Tl3, 264 aa TA06115, 236/265
(89.1%)
TP01_0868, 198/266 (74.4%) Hypothetical protein KT989587 [17] [19]
Tl5, 155 aa TA14970 (Ta5), 154/155
(99.4%)
TP02_0767 (Tp5), 153/155 (98.7%) Translation initiation factor eif-
1A
KT989588 [17, 19]
Tl6, 277 aa TA19320, 273/277
(98.6%)
TP01_0188, 274/277 (98.9%) Prohibitin KT989589 [17–19]
Tl7, 761 aa TA12105, 706/723
(97.6%)
TP02_0244 (Tp7), 699/722 (96.8%) Heat shock protein 90 KT989590 [17, 19]
Tl8, 413 a TA11565, 382/413
(92.5%)
TP02_0140 (Tp8), 362/440 82.3% Cysteine proteinase KT989591 [17, 19]
Tl9, 311 aa TA15705 (Ta9), 188/344
(54.7%)
TP02_0895 (Tp9), 169/366 (46.2%) Secreted protein in infected
cell cytoplasm
KT989592 [17, 19]
Tl10, 392 aa TA10060, 377/448
(84.2%)
TP04_0772, 358/444 (80.6%) Coronin KT989593 [18, 19]
Tl12, 858 aa TA08425, 666/894
(74.5%)
TP04_0437, 472/945 (49.9%) microneme-rhoptry antigen
(p104)
KT989594 [40]
Tl16, 275 aa TA17315, 233/315
(74.0%)
TP04_0051, 176/488 (36.1%) Surface protein precursor
(TaSP or PIM)
KT989595 [19, 41]
Tl13245, 1628
aa
TA13245, 1410/1669
(84.5%)
TP02_0052, 495/1644 (30.1%),
TP02_0051 736/1635 (45.0%)
Hypothetical protein KT989596 [18]
Tl16020, 364
aa
TA16020, 277/370
(74.9%)
TP02_0952, 168/403 (41.7%) Hypothetical protein KT989597 This study
doi:10.1371/journal.pone.0162571.t002
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immunized animal were then tested for cytotoxicity against autologous T. lestoquardi-infected
cells in a cytotoxicity assay. The CD8+ T cell lines exhibited variable levels of killing; the line
from one animal gave a maximal killing of 47% and two lines gave lower levels of lysis (4–
12%), while lysis by the remaining two lines was not significantly above background (Fig 1).
Stimulated PBMC showedMHC-restricted cytotoxicity when assayed with autologous and
unrelated infected cells (Fig 2).
Fig 1. Cytotoxic activityof CD8+ T cells from immunized sheepmeasured by indiumoxine release
assays.Effector cells were stimulated twice with irradiatedT. lestoquardi-infected cell lines andmixed with
indium oxine labeled target T. lestoquardi-infected cells at indicated effector: target ratios.
doi:10.1371/journal.pone.0162571.g001
Fig 2. MHC-specific cytotoxicity of stimulated PBMC. All sheep samples were assayed similarly and two
representative data are shown. (a) Sheep 4223 effectors lysed autologous infected cells more effectively than class I MHC-
mismatched infected cells fromSheep 4247 at all effector: target ratios. (b) Sheep 4247 effectors lysed autologous infected
cells, but not class I MHCmismatched infected cells fromSheep 4223.
doi:10.1371/journal.pone.0162571.g002
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Screening for T. lestoquardi antigens
A series of 13 T. lestoquardi candidate antigens were chosen to screen for recognition by the
parasite-specificCD8+ T cell lines. They were selected based on orthologywith T. parva and T.
annulata antigens that were shown previously to be recognised by CD8+ T cells (Table 2), thus
conforming to the premise that antigen recognition of T. lestoquardi in sheep is similar to that
of T. annulata and T. parva in cattle. DNA sequences of the respective genes were obtained
from a draft genome assembly of T. lestoquardi Lahr strain (W. Weir, unpublished data) and
genes were obtained by PCR and sub-cloning the amplicons in recombinant plasmids.
Primary autologous fibroblast cell lines derived from the five sheep were transfected with
recombinant plasmids incorporating each of the T. lestoquardi genes and screened for recogni-
tion by CD8+ T cells from the corresponding animal. Detection of a C-terminal V5 tag by
immunofluorescence staining confirmed successful transfection of cells at 24 h and 48 h (S3
Fig).
Measurement of IFNγ release by antigen-stimulated CD8+ T cells demonstrated that one of
five animals (Sheep 4247) responded to two T. lestoquardi antigens, Tl8 and Tl9 (Fig 3). There
was no detectable response to any other antigen by T cell lines from this sheep or the other 4
sheep (data not shown). The CD8+ T cell screens included transfection using two different
reagents–Lipofectamine LTX and Fugene. Although transfection efficacywas not assessed for
Fugene, both reagents yielded similar positive results (Fig 3).
Identificationof CD8+ T cell epitopes
CD8+ T cells from sheep 4247, which recognised the Tl8 and Tl9 antigens, were tested for rec-
ognition of overlapping peptides spanning the full length of each protein. Positive results were
obtained with two contiguous overlapping peptides from each antigen. These were peptides
E01 and H04 of Tl8, and peptides E06 and E07 of Tl9 (Fig 4A). However, the IFNγ production
responses detectedwith the Tl8 peptides at a concentration of 1 μg ml-1 were relatively weak.
Further titration of the Tl8 peptides (at concentrations of 0.01–10 μg ml-1) (Fig 4B) demon-
strated that a concentration of 10 μg ml-1 of Tl8 peptide was required to obtain an equivalent
IFNγ response induced by the Tl9 peptides at a concentration of 1 μg ml-1. The overlapping
peptide sequence of E01 and H04 of Tl8 was EERFKVPSYSYS, which corresponded to amino
Fig 3. CD8+ T cell response to 13 T. lestoquardiantigensmeasuredby IFNγELISA.Sheep 4247 fibroblasts were
transfected with expression constructs of candidate antigen genes using either Lipofectamine LTX or Fugene transfection
reagents for 48 h before the addition of effector cells for 72 h and IFNγELISA. The antigenswere tested separately and data are
presented as mean ± SD of biological repeats (n = 3).
doi:10.1371/journal.pone.0162571.g003
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acid residues 241–252 (Fig 4C). The overlapping peptide sequence of E06 and E07 of Tl9 was
ALRDGTKKIYEK,which corresponded to amino acid residues 271–282 (Fig 4D).
In order to identify the definitive epitopes within the Tl8241-252 (EERFKVPSYSYS) and
Tl9271-282 (ALRDGTKKIYEK) sequences, a series of truncated peptides ranging from 9 to 12
amino acids in length were tested for recognition by the respective CD8 T cell lines (Fig 5). For
the Tl8241-252, removing the first N-terminal Glu residue reduced IFNγ response, but removing
the first two N-terminal Glu residues completely abolished the response (Fig 5A). A Tyr resi-
due appears to be equally important at the C-terminus, as truncated peptides with this residue
removed elicited a poor response, whereas truncated peptides with a C-terminal Tyr249 or
Tyr251 stimulated the highest responses (Fig 5A). The 9-mer (Tl8241-249 EERFKVPSY) resulted
in the highest responses for all three experimental repeats, followed in performance by the
11-mer (Tl8241-251 EERFKVPSYSY) and the 12-mer (Tl8241-252 EERFKVPSYSYS) (Fig 5A).
For Tl9, a C-terminal truncated 9-mer peptide was recognised as effectively as the full length
12 mer (Fig 5B). Removing one or more of the first 4 N-terminal residues (Ala, Lys, Try, Ileu)
resulted in a complete lack of T cell recognition (Fig 5B). Hence the shortest antigenic peptide
to induce a strong IFNγ response was the 9-mer Tl9271-279 ALRDGTKKI (Fig 5B).
A comparison of the amino acid sequence of Tl8 to that of the T. annulata and T. parva
orthologues Ta8 and Tp8 showed 87.65% of residues were similar. Tl8241-249 EERFKVPSY did
not overlap with the previously identified epitope of Tp8379-387 CGAELNHFL [29] (S4 Fig).
The sequence of the corresponding 9 amino acid regions in Ta8 and Tp8 each differed by only
one amino acid residue from the Tl8 epitope sequence (S4A Fig). A similar comparison of the
amino acid sequences of Tl9 to Ta9 and Tp9 revealed only 51.9% similarity, although the N-
terminal predicted signal peptide was highly conserved (S4B Fig). The latter is consistent with
previous comparisons of Ta9 and Tp9 [19]. The positions of the epitope in the Tl9 protein dif-
fered from those of previously identified epitopes in the T. annulata and T. parva orthologues
(S4 Fig). In contrast to Tl8, the amino acid sequences of the corresponding 9 amino acid
Fig 4. Tl8 and Tl9 peptide screen for CTL epitopes. (a) Peptides positively identified from peptide pools were incubated at
1 μgml-1 with fibroblasts and assayed for IFNγ production by autologous stimulated effector cells. T. lestoquardi-infected cells
incubatedwith effectors served as a positive control and effectors only served as a negative control. (b) Tl8 peptideswere
titrated and assayed for IFNγ production by autologous stimulated effector cells, which increased with increasing concentrations
of peptides. (c) Overlapping peptide sequence of H04 and E01 of Tl8. (d) Overlapping peptide sequence of E06 and E07 of Tl9.
doi:10.1371/journal.pone.0162571.g004
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regions in Ta9 and Tp9 differed at 5 and 6 amino acid positions respectively from the Tl9
sequence.
Discussion
A subunit vaccine against T. lestoquardi is an attractive alternative strategy to live attenuated
vaccines; however, there is limited available data on T. lestoquardi antigens and the immune
responses against them. This is the first report of CD8+ T cells from immunized sheep having
cytotoxic activity against T. lestoquardi-infected lymphocytes and identification of potential T.
lestoquardi antigens that can be recognised by this CD8+ T cell response. In addition, the
results confirm that orthologues of antigens that are recognised by the bovine CD8+ T cell
response are also recognised by the ovine immune response, although the identified epitopes
may vary.
While initial cytotoxicity assays lacked a control to confirm specificity against parasite-
infected cells, subsequent IFNγ assays were carried out with enriched CD8+ T cells and
included uninfected fibroblasts, confirming parasite-specific responses mediated by CD8+ T
cells. The relatively low cytotoxic activity of the sheep 4247 CD8+ T cell line nonetheless having
a robust IFNγ response to Tl8 and Tl9 indicates that levels of cytotoxicity do not necessarily
reflect the CD8 T cell IFNγ response. This is similar to observationswith CD8+ T cell lines gen-
erated from cattle immunized against T. annulata, where there was variability in cytotoxicity
but a consistent and specific IFNγ response to antigens [30].
Tl8 is predicted as a cysteine proteinase and Tl9 has no known predicted function but is
unique to transforming Theileria species; a Ta9/Tp9 orthologuewas absent in the non-trans-
forming species,T. orientalis [42]. Sequence analysis by SignalP 4.1 [43] did not predict a signal
peptide in Tl8 or Ta8, while Tp8 has a predicted signal anchor peptide [17], suggesting that Tl8
and Ta8 may not be secreted proteins, while Tp8 may be a membrane protein. In contrast, Tl9
is predicted to contain a signal peptide, similar to Ta9 and Tp9. Ta9 has been reported to be
secreted into the cytoplasm of macroschizont infected cells [19]. Tp8, Tp9 and Ta9 have been
shown to be antigenic in cattle [17, 19, 29].
The detection of T cell responses to two of only thirteen candidate antigens, in one of five
immunized sheep is a reasonable detection rate relative to previous antigen screening studies
for T. parva and T. annulata [17, 19]. The data confirms that some parasite gene products
serve as antigens in several Theileria species, and that T. lestoquardi antigens are recognizedby
Fig 5. IFNγ responseof antigenicepitopesof (a) Tl8241-252 (EERFKVPSYSYS) and (b) Tl9271-282 (ALRDGTKKIYEK).
Different peptide sequence combinations ranging from 9-mer to 12-mer at 1 μgml-1 were incubated for 24 h with fibroblasts
before adding effector cells for 72 h. Cell supernatants were harvested for IFNγ assay (n = 2).
doi:10.1371/journal.pone.0162571.g005
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CD8+ T cells from different animals in a preferential manner, as is the case for T. parva and T.
annulata in cattle [19, 29, 31]. Previous studies of T. parva indicated that the latter reflects an
effect of MHC type on antigenic dominance. In this regard, the MHC type of sheep 4247 dif-
fered from that of the other sheep examined. A high peptide concentration was required to
detect the Tl8 epitope, which was likely due to peptide insolubility issues rather than a lack of
reactivity per se, for the following reasons: a) RPMI was used for resuspension of peptide and
precipitates were observed;b) specific T cells were present, as pTl8 transfected fibroblast con-
trols produced high levels of IFNγ (5.3 ± 1.4 ng ml-1 for LTX and 3.9 ± 0.9 ng ml-1 for Fugene);
c) BLASTP of the Tl8 epitope sequence against the translated sequence of the T. lestoquardi
genome did not result in any high-scoringmatches (other than Tl8), arguing against the possi-
bility that the detected Tl8 response represented cross-reactivity with a true epitope in another
protein [44].
For both Tl8 and Tl9, we determined that 9-mer peptides were optimal for inducing an
IFNγ response. This length is consistent with T. parva antigenic peptides derived from Tp2,
Tp4, Tp5, Tp7 and Tp8 in cattle, which are all 9-mers [29]. However, the peptide sequences
did not overlap with previously identified antigenic epitope sites in the Tp8 and Ta9 proteins.
This may be due to differences in the peptide binding sites of MHC I molecules of sheep and
cattle, other antigen-dependent factors such as peptide conformations and unidentified epi-
topes, or a combination of unidentifiedMHC I molecules and epitopes. In this regard, predic-
tion of T. parva and T. annulata epitopes binding to bovineMHC I (BoLA)molecules by
NetMHCpan has generated a greater number of epitopes and binding BoLAmolecules than
peptidemapping or truncation assays [45, 46]. This tool could be useful for the prediction of
additional putative T. lestoquardi epitopes whenmore data on ovine MHC I alleles becomes
available.
Analysis of the MHC class I diversity in sheep has been limited to alleles from Scottish
Blackface [39] and French Prealpe breeds (K. Ballingall, unpublished data). Therefore, it was
unsurprising that most alleles identified in the Swaledale/Leicester cross sheep used in this
study were novel and diverse. However, it is of interest that alleles 2G, H, I, J from the respond-
ing sheep 4247 have a unique polymorphic cluster corresponding to changes Phe113 and
Met114 of the reference sequenceN00301; Met114 was predicted to bind peptides [33]. Allele
2K also possessed this unique cluster, although it is one of three alleles identified in an unre-
sponsive sheep.
To summarize, we were able to identify two T. lestoquardi proteins that are recognised by a
CD8+ T cell line established in vitro from an MHC I defined immune sheep, indication that
they are involved in potentially protective T cells response in vivo against T. lestoquardi-
infected leukocytes. Furthermore, we were able to deduce the minimal length peptides required
for recognition of these antigens by a CD8+ T cells response. More comprehensive antigen
screens and additional studies are necessary to determine the genetic diversity of both parasite
and host, and to test the ability of identified proteins to induce protection against T. lestoquardi
challenge.While the use of an attenuated T. lestoquardi-infected cell line has shown protection
in one study [12], a more targeted approach to vaccination, ideally utilising antigens conserved
between different strains of T. lestoquardi, has practical advantages in terms of safety, produc-
tion, storage and administration.
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S1 Fig. Alignment of translated allele sequences and comparison to an MHC class I
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S2 Fig. CD8+ T cells was the predominant cell population in PBMCs of sheep immune to T.
lestoquardi after three stimulations.
(TIF)
S3 Fig. Expression of T. lestoquardi genes in transfected fibroblasts of either sheep 1263 or
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